Skip to main content
OpenTrials
Completed

NCT Number: NCT01534923

Doctor-Patient Communication About Colorectal Cancer Screening

The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Albert Einstein College of Medicine, The Bronx, New York, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Physicians

  • Attending physicians or third year residents specializing in internal medicine or family medicine, as per the medical director from the clinic.
  • Clinic is based at a NYC RING-affiliated practice.
  • English speaking; Due to limited resources, we cannot have each audio recorded consultation translated therefore, the consultation needs to be in English.

Patients

  • Ages 50-75 years old, per the United States Preventive Services Task Force recommendations for screening. This will be determined by a pre-screening of medical records by the RSA.
  • Due for colorectal cancer screening at the time of the visit, ascertained through patient self-report (e.g., no colonoscopy within the past 10 years, no flexible sigmoidoscopy or barium enema within the past five years, and no FOBT within the past year).
  • Coming for either an annual physical exam or chronic care follow up visit, per patient self-report.
  • Planning to consult with the physician in English, per patient self-report. Due to limited resources, we cannot have each audio recorded consultation translated therefore, the consultation needs to be in English.

Exclusion criteria

  • History of colorectal cancer, per patient self-report or per EMR..
  • History of polyps being removed, per patient self-report.
  • Colonoscopy scheduled in EMR at time of screening.

Treatment and study plan

Surveys

Behavioral

The intervention will be the audio-recording of the physician-patient consultation, patient and doctor surveys. These audio recordings will be coded. It will also include follow-up phone calls with patients.

Primary outcomes

  1. describe doctor-patient communication about CRC screening

    Time frame: 2 years

    screening adherence through self report. Screening adherence will be assessed by contacting the patients and asking them if they received the CRC screening test their doctor ordered at the audio recorded visit.

Secondary outcomes

  1. quality of doctor-patient communication about CRC screening and low-income patients' screening outcomes.

    Time frame: 2 years

  2. examine the association between the quality of doctor-patient communication about CRC screening and low-income patients' screening outcomes

    Time frame: 2 years

    intent to be screened (immediately after the consultation) using the item from Geller et al.25 and 2) self-efficacy for screening (immediately after consultation) in case there are few events of actual screening.

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

  • Albert Einstein College of Medicine
  • HHC, Gun HIll and Tremont
  • NYC RING, Director
  • Virginia Commonwealth University

Registry information

Important dates

Study start
2012
Primary completion
2019
Study completion
2019
First posted
Feb 17, 2012
Registry last updated
Jan 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.